A short history of the B cell-associated surface molecule CD40
NONE
Main Author: | Edward A Clark |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00472/full |
Similar Items
-
Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
by: Mahdi Fasihi-Ramandi, et al.
Published: (2015-10-01) -
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
by: Letizia Polito, et al.
Published: (2013-10-01) -
Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
by: Raquel Delgado, et al.
Published: (2021-06-01) -
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
by: Katherine A. Riccione, et al.
Published: (2018-12-01) -
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
by: Maria A. Argiriadi, et al.
Published: (2019-08-01)